Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial

Diabetologia

Volumn 59, Issue 5, 2016, Pages 945-953

  Cummings, David E ^a   Arterburn, David E ^b   Westbrook, Emily O ^b   Kuzma, Jessica N ^c   Stewart, Skye D ^d   Chan, Chun P ^d   Bock, Steven N ^e   Landers, Jeffrey T ^f   Kratz, Mario ^c   Foster Schubert, Karen E ^a   Flum, David R ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^f Group Health Research   (United States)

Author keywords

Bariatric surgery; Diabetes; Intensive lifestyle; Metabolic surgery; Randomised controlled trial

Indexed keywords

GLUCOSE; ANTIDIABETIC AGENT;

ADULT; ADVERSE OUTCOME; AEROBIC EXERCISE; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIABETIC DIET; FEMALE; GLYCEMIC CONTROL; HUMAN; INTENSIVE LIFESTYLE AND MEDICAL INTERVENTION; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; ROUX Y ANASTOMOSIS; SCREENING; SYSTOLIC BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; GASTRIC BYPASS SURGERY; HEALTHY LIFESTYLE; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; HEALTHY LIFESTYLE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84961210114     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-3903-x     Document Type: Article

References (34)

1. Murray CJ, Vos T, Lozano R et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–2223
2. Wong K, Glovaci D, Malik S et al (2012) Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification. J Diabetes Complications 26:169–174
3. Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256 e5
4. Thaler JP, Cummings DE (2009) Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150:2518–2525
5. Sjostrom L, Lindroos AK, Peltonen M et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683–2693
6. Carlsson LM, Peltonen M, Ahlin S et al (2012) Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 367:695–704
7. Sjostrom L, Peltonen M, Jacobson P et al (2012) Bariatric surgery and long-term cardiovascular events. JAMA 307:56–65
8. Sjostrom L, Gummesson A, Sjostrom CD et al (2009) Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 10:653–662
9. Sjostrom L, Narbro K, Sjostrom CD et al (2007) Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741–752
10. Adams TD, Gress RE, Smith SC et al (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753–761
11. Arterburn D, Flum DR, Westbrook EO et al (2013) A population-based, shared decision-making approach to recruit for a randomized trial of bariatric surgery versus lifestyle for type 2 diabetes. Surg Obes Relat Dis 9:837–844
12. Kolotkin RL, Crosby RD, Pendleton R, Strong M, Gress RE, Adams T (2003) Health-related quality of life in patients seeking gastric bypass surgery vs non-treatment-seeking controls. Obes Surg 13:371–377
13. van Nunen AM, Wouters EJ, Vingerhoets AJ, Hox JJ, Geenen R (2007) The health-related quality of life of obese persons seeking or not seeking surgical or non-surgical treatment: a meta-analysis. Obes Surg 17:1357–1366
14. Encinosa WE, Bernard DM, Du D, Steiner CA (2009) Recent improvements in bariatric surgery outcomes. Med Care 47:531–535
15. Courcoulas AP, Yanovski SZ, Bonds D et al (2014) Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. JAMA Surg 149:1323–1329
16. Schauer PR, Kashyap SR, Wolski K et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366:1567–1576
17. Mingrone G, Panunzi S, De Gaetano A et al (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366:1577–1585
18. Ikramuddin S, Korner J, Lee WJ et al (2013) Roux-en-Y gastric bypass vs. intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. The Diabetes Surgery Study randomized clinical trial. JAMA 309:2240–2249
19. Dixon JB, O'Brien PE, Playfair J et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299:316–323
20. Halperin F, Ding SA, Simonson DC et al (2014) Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg 149:716–726
21. Courcoulas AP, Goodpaster BH, Eagleton JK et al (2014) Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg 149:707–715
22. Schauer PR, Bhatt DL, Kirwan JP et al (2014) Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med 370:2002–2013
23. Ludwig DS, Ebbeling CB, Livingston EH (2012) Surgical vs lifestyle treatment for type 2 diabetes. JAMA 308:981–982
24. Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403
25. The Look AHEAD Research Group, Wing RR, Bolin P et al (2013) Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369:145–154
26. Inzucchi SE, Bergenstal RM, Buse JB et al (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35:1364–1379
27. Buse JB, Caprio S, Cefalu WT et al (2009) How do we define cure of diabetes? Diabetes Care 32:2133–2135
28. Arterburn DE, Westbrook EO, Bogart TA, Sepucha KR, Bock SN, Weppner WG (2011) Randomized trial of a video-based patient decision aid for bariatric surgery. Obesity (Silver Spring) 19:1669–1675
29. Gloy VL, Briel M, Bhatt DL et al (2013) Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 347:f5934
30. Flum DR, Belle SH, King WC et al (2009) Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 361:445–454
31. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I (2007) Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 142:621–632, discussion 632–635
32. Demaria EJ, Winegar DA, Pate VW, Hutcher NE, Ponce J, Pories WJ (2010) Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg 252:559–566, discussion 566–567
33. Pournaras DJ, Aasheim ET, Sovik TT et al (2012) Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg 99:100–103
34. CDCP NIH (1991) Gastrointestinal surgery for severe obesity. Ann Intern Med 115:956–961